Benjamin Harshbarger - Net Worth and Insider Trading

Benjamin Harshbarger Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Benjamin Harshbarger owns 3 companies in total, including Astria Therapeutics Inc (ATXS) , Novelion Therapeutics Inc (NVLNF) , and Aegerion Pharmaceuticals Inc (AEGR) .

Click here to see the complete history of Benjamin Harshbarger’s form 4 insider trades.

Insider Ownership Summary of Benjamin Harshbarger

Ticker	Comapny	Transaction Date	Type of Owner
ATXS	Astria Therapeutics Inc	2020-06-08	Secretary and General Counsel
NVLNF	Novelion Therapeutics Inc	2019-05-09	See Remarks
AEGR	Aegerion Pharmaceuticals Inc	2016-11-29	General Counsel and Secretary

Benjamin Harshbarger Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Benjamin Harshbarger Ownership Network

Ownership Network List of Benjamin Harshbarger

No Data

Ownership Network Relation of Benjamin Harshbarger

Benjamin Harshbarger Owned Company Details

What does Astria Therapeutics Inc do?

Who are the key executives at Astria Therapeutics Inc?

Benjamin Harshbarger is the Secretary and General Counsel of Astria Therapeutics Inc. Other key executives at Astria Therapeutics Inc include Chief Medical Officer Christopher Morabito , director & 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Chief Business Officer Andrea Matthews .

Astria Therapeutics Inc (ATXS) Insider Trades Summary

Over the past 18 months, Benjamin Harshbarger made no insider transaction in Astria Therapeutics Inc (ATXS). Other recent insider transactions involving Astria Therapeutics Inc (ATXS) include a net purchase of 5,204,223 shares made by Perceptive Life Sciences Master Fund Ltd , and a net sale of 20,000 shares made by Christopher Morabito .

In summary, during the past 3 months, insiders sold 20,000 shares of Astria Therapeutics Inc (ATXS) in total and bought 2,481,350 shares, with a net purchase of 2,461,350 shares. During the past 18 months, 20,000 shares of Astria Therapeutics Inc (ATXS) were sold and 5,204,223 shares were bought by its insiders, resulting in a net purchase of 5,184,223 shares.

Astria Therapeutics Inc (ATXS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Astria Therapeutics Inc Insider Transactions

No Available Data

What does Novelion Therapeutics Inc do?

Who are the key executives at Novelion Therapeutics Inc?

Benjamin Harshbarger is the See Remarks of Novelion Therapeutics Inc. Other key executives at Novelion Therapeutics Inc include 10 percent owner Broadfin Healthcare Master Fund Ltd , 10 percent owner Broadfin Capital, Llc , and 10 percent owner Kevin Kotler .

Novelion Therapeutics Inc (NVLNF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Novelion Therapeutics Inc (NVLNF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Novelion Therapeutics Inc (NVLNF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Novelion Therapeutics Inc (NVLNF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Novelion Therapeutics Inc Insider Transactions

No Available Data

What does Aegerion Pharmaceuticals Inc do?

Who are the key executives at Aegerion Pharmaceuticals Inc?

Benjamin Harshbarger is the General Counsel and Secretary of Aegerion Pharmaceuticals Inc. Other key executives at Aegerion Pharmaceuticals Inc include director & Chief Executive Officer Mary T Szela , other: See Remarks Gregory D Perry , and 10 percent owner Broadfin Healthcare Master Fund Ltd .

Aegerion Pharmaceuticals Inc (AEGR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aegerion Pharmaceuticals Inc (AEGR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aegerion Pharmaceuticals Inc (AEGR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aegerion Pharmaceuticals Inc (AEGR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aegerion Pharmaceuticals Inc Insider Transactions

No Available Data

Benjamin Harshbarger Mailing Address

Above is the net worth, insider trading, and ownership report for Benjamin Harshbarger. You might contact Benjamin Harshbarger via mailing address: One Main Street, Suite 800, Cambridge Ma 02142.

Discussions on Benjamin Harshbarger

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.